CHC Healthcare Group (4164) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.064x

Based on the latest financial reports, CHC Healthcare Group (4164) has a cash flow conversion efficiency ratio of 0.064x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$516.12 Million ≈ $16.26 Million USD) by net assets (NT$8.08 Billion ≈ $254.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CHC Healthcare Group balance sheet quality to measure how much of total assets are equity-financed.

CHC Healthcare Group - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how CHC Healthcare Group's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check CHC Healthcare Group cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

CHC Healthcare Group Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CHC Healthcare Group ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Mechema Chemicals Int TWO:4721	0.108x
Terra Metals Ltd AU:TM1	-0.001x
S-Oil Corp Pref KO:010955	0.103x
AN2 Therapeutics Inc NASDAQ:ANTX	-0.099x
SPML Infra Limited NSE:SPMLINFRA	-0.023x
Sahamitr Pressure Container Public Company Limited BK:SMPC	0.019x
EGH Acquisition Corp. Class A Ordinary Shares NASDAQ:EGHA	-0.002x
Satellos Bioscience Inc. Common Stock NASDAQ:MSLE	-0.261x

Annual Cash Flow Conversion Efficiency for CHC Healthcare Group (2009–2025)

The table below shows the annual cash flow conversion efficiency of CHC Healthcare Group from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see CHC Healthcare Group stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$8.08 Billion ≈ $254.59 Million	NT$1.03 Billion ≈ $32.39 Million	0.127x	+758.50%
2024-12-31	NT$6.70 Billion ≈ $211.24 Million	NT$99.37 Million ≈ $3.13 Million	0.015x	-89.57%
2023-12-31	NT$6.78 Billion ≈ $213.47 Million	NT$962.59 Million ≈ $30.33 Million	0.142x	+38.53%
2022-12-31	NT$6.40 Billion ≈ $201.73 Million	NT$656.66 Million ≈ $20.69 Million	0.103x	-6.54%
2021-12-31	NT$6.31 Billion ≈ $198.92 Million	NT$692.79 Million ≈ $21.83 Million	0.110x	-28.08%
2020-12-31	NT$6.00 Billion ≈ $189.03 Million	NT$915.47 Million ≈ $28.84 Million	0.153x	-31.81%
2019-12-31	NT$5.32 Billion ≈ $167.53 Million	NT$1.19 Billion ≈ $37.48 Million	0.224x	+193.99%
2018-12-31	NT$5.13 Billion ≈ $161.73 Million	NT$390.69 Million ≈ $12.31 Million	0.076x	+27.30%
2017-12-31	NT$4.91 Billion ≈ $154.83 Million	NT$293.82 Million ≈ $9.26 Million	0.060x	-73.87%
2016-12-31	NT$4.97 Billion ≈ $156.57 Million	NT$1.14 Billion ≈ $35.83 Million	0.229x	+152.27%
2015-12-31	NT$5.57 Billion ≈ $175.37 Million	NT$504.90 Million ≈ $15.91 Million	0.091x	-32.92%
2014-12-31	NT$4.69 Billion ≈ $147.78 Million	NT$634.23 Million ≈ $19.98 Million	0.135x	-27.47%
2013-12-31	NT$4.66 Billion ≈ $146.91 Million	NT$869.31 Million ≈ $27.39 Million	0.186x	+141.53%
2012-12-31	NT$3.83 Billion ≈ $120.80 Million	NT$295.94 Million ≈ $9.32 Million	0.077x	-53.16%
2011-12-31	NT$2.90 Billion ≈ $91.23 Million	NT$477.21 Million ≈ $15.03 Million	0.165x	-32.11%
2010-12-31	NT$2.10 Billion ≈ $66.21 Million	NT$510.14 Million ≈ $16.07 Million	0.243x	+415.73%
2009-12-31	NT$805.32 Million ≈ $25.37 Million	NT$-61.92 Million ≈ $-1.95 Million	-0.077x	--

About CHC Healthcare Group

TW:4164 Taiwan Medical Distribution

Market Cap

$160.30 Million

NT$5.09 Billion TWD

Market Cap Rank

#17323 Global

#859 in Taiwan

Share Price

NT$26.05

Change (1 day)

+0.19%

52-Week Range

NT$26.00 - NT$51.70

All Time High

NT$73.80